Spinal Cord Stimulation Restores Motor Function in SMA

SMA
Spinal Cord Stimulation Restores Motor Function in SMA

Spinal Cord Stimulation Restores Neural Function in SMA Patients

A groundbreaking clinical trial has demonstrated that spinal cord stimulation can help restore motor function in patients with spinal muscle atrophy (SMA), a severe neurodegenerative disease. Researchers at the University of Pittsburgh found that this drug-free, minimally invasive therapy improves muscle strength, walking ability, and fatigue levels, offering a new hope for treating neurodegenerative conditions.

Spinal Cord Stimulation: A New Approach to SMA Treatment

SMA is a genetic disorder that causes progressive loss of motor neurons, leading to severe muscle weakness and movement impairments. Current treatments, including gene therapy and medications, focus on slowing disease progression but do not reverse damage to nerve cells.

In this new study, researchers used spinalcord electrical stimulation to reactivate silent motor neurons, essentially rewiring neural connections to improve mobility and muscle function.

“To counteract neurodegeneration, we need two things—stop neuron death and restore function of surviving neurons,” said Dr. Marco Capogrosso, study co-author.

Clinical Trial Results: A Life-Changing Breakthrough

Three SMA patients participated in a 29-day pilot trial, undergoing spinalcord stimulation five times a week. The results were remarkable:

✔ All participants showed improved motor function
✔ Increased walking endurance by at least 20 meters
✔ Reduced fatigue and improved daily activity performance
✔ Improved motoneuron electrical function and strength

“Patients don’t expect to get better over time—but that’s exactly what we saw,” said Dr. Elvira Pirondini.

This therapy offers a potential alternative for other neurodegenerative diseases, including ALS and Huntington’s disease, by stimulating damaged neural pathways to restore movement.

Future Prospects: Expanding the Treatment

With encouraging early results, researchers plan to launch larger clinical trials to determine the long-term effectiveness of this approach. If successful, spinal cord stimulation could redefine treatment strategies for neurodegenerative diseases, providing millions of patients with renewed mobility and hope.

 

More Information: First-in-human study of epidural spinal cord stimulation in individuals with spinal muscular atrophy, Nature Medicine (2025). DOI: 10.1038/s41591-024-03484-8.

Dr. Thota Chandana, PharmD, is a seasoned healthcare content creator specializing in scientific articles, medical blogs, and medcom materials. She combines her clinical expertise with a passion for clear communication, delivering precise, evidence-based content tailored for healthcare professionals. Her work ensures relevance and value for HCPs, making complex healthcare topics accessible and engaging.

more recommended stories